Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy

Authors

Devon Miller, University of Wisconsin-Madison
John A Livingston, University of Texas MD Anderson Cancer Center
Yeonhee Park, University of Wisconsin-Madison
Kristi Posey, University of Texas MD Anderson Cancer Center
Sonia Godbole, Washington University School of Medicine in St. Louis
Keith Skubitz, University of Minnesota - Twin Cities
Steven I Robinson, Mayo Clinic
Mark Agulnik, City of Hope
Lara E Davis, Oregon Health & Science University
Brian A Van Tine, Washington University School of Medicine in St. Louis
Angela C Hirbe, Washington University School of Medicine in St. Louis
Amanda Parkes, University of Wisconsin-Madison

Journal

Cancer Medicine

Publication Date

9-1-2022

Volume

11

Issue

18

First Page

3471

Last Page

3478

Document Type

Open Access Publication

DOI

10.1002/cam4.4707

Rights and Permissions

Miller, D, Livingston, JA, Park, Y, et al. Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy. Cancer Med. 2022; 11(18): 3471– 3478. doi: 10.1002/cam4.4707 © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Miller, Devon; Livingston, John A; Park, Yeonhee; Posey, Kristi; Godbole, Sonia; Skubitz, Keith; Robinson, Steven I; Agulnik, Mark; Davis, Lara E; Van Tine, Brian A; Hirbe, Angela C; and Parkes, Amanda, "Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy." Cancer Medicine. 11, 18. 3471 - 3478. (2022).
https://digitalcommons.wustl.edu/oa_4/684